ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
4.410
-0.170 (-3.71%)
At close: Dec 20, 2024, 4:00 PM
4.190
-0.220 (-4.99%)
After-hours: Dec 20, 2024, 4:34 PM EST
ImmuCell Employees
As of December 31, 2023, ImmuCell had 79 total employees, including 74 full-time and 5 part-time employees. The number of employees increased by 5 or 6.76% compared to the previous year.
Employees
79
Change (1Y)
5
Growth (1Y)
6.76%
Revenue / Employee
$301,747
Profits / Employee
-$48,241
Market Cap
39.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CASI Pharmaceuticals | 176 |
Enzo Biochem | 136 |
CollPlant Biotechnologies | 75 |
Rallybio | 43 |
OneMedNet | 20 |
Cardio Diagnostics Holdings | 9 |
Lexaria Bioscience | 7 |
ICCC News
- 5 weeks ago - ImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 6 weeks ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 2 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 - GlobeNewsWire
- 4 months ago - ImmuCell Corporation (ICCC) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 - GlobeNewsWire
- 4 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 - GlobeNewsWire
- 5 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - GlobeNewsWire